21/08/14 15:45:22.91 Ga/Oj10X9.net
August 6, 2021: Early Treatment of COVID-19 with Repurposed Therapies: The TOGETHER Adaptive Platform Trial (Edward Mills, PhD, FRCP)
After many trial therapies showed little effect, Fluvoxamine, an SSRI commonly used for depression, has shown promising results when repurposed to treat COVID-19.
URLﾘﾝｸ(rethinkingclinicaltrials.org)
Fluvoxamine(フルボキサミン)がコロナに対して有意な結果
フルボキサミンマレイン酸塩錠50mg「サワイ」薬価18.1円